Chappell Dale - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Chappell Dale
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-10-18
Sale
2023-10-20
6:50 pm
HUMANIGEN INCHGENChappell Dale
BLACK HORSE CAPITAL LP
BLACK HORSE CAPITAL MANAGEMENT LLC
Black Horse Capital Master Fund Ltd.
Cheval Holdings Ltd.
Chief Scientific Officer
10% Owner
386,350$0.011$4,2508,398,871
(Indirect)
View
2022-05-18
Purchase
2022-05-20
5:57 pm
HUMANIGEN INCHGENChappell Dale
BLACK HORSE CAPITAL LP
Black Horse Capital Master Fund Ltd.
BLACK HORSE CAPITAL MANAGEMENT LLC
Cheval Holdings Ltd.
Chief Scientific Officer
10% Owner
1,042,996$2.1707$2,263,9918,675,081
(Indirect)
View
2022-03-11
Purchase
2022-03-15
6:23 pm
HUMANIGEN INCHGENChappell Dale
BLACK HORSE CAPITAL MANAGEMENT LLC
BLACK HORSE CAPITAL LP
Black Horse Capital Master Fund Ltd.
Cheval Holdings Ltd.
Chief Scientific Officer
10% Owner
1,000,000$3$3,000,0007,944,985
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-07-27
Option Award
2022-07-29
6:31 pm
2023-07-27
2032-07-26
HUMANIGEN INCHGENChappell Dale
Chief Scientific Officer
10% Owner
518,205$0518,205
(Direct)
View
2022-01-12
Option Award
2022-01-14
5:06 pm
2023-01-12
2032-01-11
HUMANIGEN INCHGENChappell Dale
Chief Scientific Officer
10% Owner
36,550$036,550
(Direct)
View
2021-12-31
Option Award
2022-01-04
6:20 pm
2022-03-31
2031-12-30
HUMANIGEN INCHGENChappell Dale
Chief Scientific Officer
10% Owner
44,600$044,600
(Direct)
View
2021-09-30
Option Award
2021-10-04
8:07 pm
2021-10-31
2031-09-30
HUMANIGEN INCHGENChappell Dale
Chief Scientific Officer
10% Owner
22,626$022,626
(Direct)
View